Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
A Randomized Study Comparing Carboplatin and Thalidomide With Carboplatin Alone in Patients With Stage Ic - IV Ovarian Cancer
Sponsor: Cancer Research UK
A PHASE2 clinical study on Ovarian Cancer, this trial is completed. The trial is conducted by Cancer Research UK and has accumulated 5 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Aug 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Research UK
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Oxford, United Kingdom